Maxime Feyeux

@FeyeuxMaxime

#PhD #StemCell #iPS #CellTherapy / Co-founder & CSO of @treefrogtx / Host of the webcast #InTheStemCellJungle

Bordeaux, France stemcelljungle.com Joined December 2020

95 Following 79 Followers 68 Posts

Latest posts 5

Maxime Feyeux @FeyeuxMaxime Mar 29, 2023

We get this question a lot: Can you #differentiate #pluripotent #stemcells into any cell type in C-Stem™-generated alginate capsules?
Here a quick answer. Link to our latest paper on #iPSC expansion, with some trilineage data (Fig. 3): sciencedirect.com/science/articl…

1:39

Maxime Feyeux @FeyeuxMaxime Mar 10, 2023

What does the C-Stem™ platform bring to the #CellTherapy field? For once I am the one answering questions in this short video about our latest paper in #Biomaterials. 5 other videos addressing FAQS about C-Stem are online: treefrog.fr/stemcelljungle/

1:45

Maxime Feyeux @FeyeuxMaxime Feb 28, 2023

Over 100 #CellTherapy #trials based on #ES & #iPS cells from 2010 to 2023 listed here !
And you can sort this list by date, target organ, indication, cell type ES/IPS, country, number of patients... Pretty cool !

TreeFrog Therapeutics @treefrogtx Feb 28, 2023

Releasing a pretty exhaustive list of cell therapy trials based on iPS & ES cells! Access for free and share!
treefrog.fr/stemcelljungle…
@pknoepfler @alliancerm @ISSCR @ISCTglobal @STEMCELLTech @nyscf @JSRM_Official @LINKJ20160324 @IPSCtherapies @ESC_iPSC_News

View quoted post on X

Maxime Feyeux @FeyeuxMaxime Oct 27, 2022

So far, approved CAR-T cell therapies are exclusively autologous products. What’s the promise behind allogeneic T and NK cells for cancer patients ? I asked Neil Sheppard D.Phil, Associate Professor and Head of the TCEL at UPenn.

Full episode : lnkd.in/e94cD9eS

1:45

Maxime Feyeux @FeyeuxMaxime Oct 7, 2022

#TME #CARTs: What about T cell-based strategies in solid tumors like TIL (@IovanceBio) & TCR-T (@Adaptimmune, @immatics) therapies ? I asked Neil Sheppard D.Phil, Adjunct Associate Prof., head of the TCEL at @Penn

#InTheStemCellJungle

>> youtube.com/watch?v=hOfZBp…

www.youtube.com The challenge of targeting solid tumors with T cells I TIL therapies I TCR Ts While solid tumors represent the vast majority of cancers, most com...